Hypera SA (HYPMY) recently announced a dividend of $0.06 per share, payable on a date yet to be confirmed, with the ex-dividend date set for October 5, 2023. As investors eagerly anticipate this ...

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone ...

Hypera is a top pharmaceutical company in Brazil, dominating the OTC market with a strong brand portfolio. Overleveraged acquisitions, Brazil's slowing pharma market, and high interest rates have ...

Hypera SA (HYPMY) recently announced a dividend of $0.02 per share, payable on a date yet to be confirmed, with the ex-dividend date set for 2024-03-22. As investors look forward to this upcoming ...

Hypera S.A. Sponsored ADR ( (HYPMY)) has released its Q3 earnings. Here is a breakdown of the information Hypera S.A. Sponsored ADR presented to its investors. Hypera S.A., operating in the ...

SAO PAULO, March 21 (Reuters) - Brazilian drugmaker Hypera (HYPE3.SA), opens new tab plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's (NOVOb.CO), ...

Brazil's leading pharmaceutical company Hypera SA believes it can sustain market share gains it had this year and deliver on guidance for 2022, CEO Breno Oliveira told analysts in a conference call on ...

SAO PAULO (Reuters) - Brazil's Hypera Pharma said on Monday that it has signed a contract to buy a portfolio of 18 products from Japan's Takeda Pharmaceutical Co for $825 million. Shares in Hypera ...

Memory and storage manufacturer Silicon Power just released the Hypera microSDXC Express Card designed for the Switch 2, arriving in 256GB, 512GB, and 1TB capacities. The company says that this memory ...

Hypera Pharma, along with all Rimini Street clients, benefits from the Company’s flexible, premium-level enterprise software support model, including its industry-leading Service Level Agreement (SLA) ...